Presentation
14 August 2019 Clinical application: PDT with Tom Dougherty (Conference Presentation)
Author Affiliations +
Proceedings Volume 11070, 17th International Photodynamic Association World Congress; 1107019 (2019) https://doi.org/10.1117/12.2525955
Event: 17th International Photodynamic Association World Congress, 2019, Cambridge, Massachusetts, United States
Abstract
Since 1978 the initial research on PDTand PDD using canine lung cancer model and then clinical research of early stage cancers of lung, esophagus, stomach and cervix was performed with hematoporphyrin derivative and argon dye laser. A lot of meetings on PRT which was called initially, mainly in USA, Late in 1980's IPA was founded during the International Meeting of Clinical Application of PRT in Tokyo. After the extended clinical trials of PDT on early stage cancers by the support of Government in 1980' Japanese Government approved PDT with Photofrin and argon dye laser or excimer dye laser for clinical use in 1992. A New photosensitizer of Laserphyrin ( Chrolin e6) wad developed after the preclinical investigation by Prof. David Kessel. This photosensitizer showed less skin photosensitibity than previous Photofrin.
Conference Presentation
© (2019) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Harubumi Kato "Clinical application: PDT with Tom Dougherty (Conference Presentation)", Proc. SPIE 11070, 17th International Photodynamic Association World Congress, 1107019 (14 August 2019); https://doi.org/10.1117/12.2525955
Advertisement
Advertisement
KEYWORDS
Photodynamic therapy

Lung cancer

Cancer

Cervix

Clinical research

Clinical trials

Esophagus

Back to Top